Stephen Machatha

Insider Reports History

Location
Lexington, MA
Signature
/s/ Stephen Machatha
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Machatha:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aldeyra Therapeutics, Inc. Chief Development Officer Common Stock 221,799 $1,142,641 $5.15 11 Aug 2025 Direct
Aldeyra Therapeutics, Inc. Chief Development Officer Stock Option (right to buy) 202,427 04 Mar 2025 Direct

Insider Reports Filed by Stephen Machatha

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALDX Aldeyra Therapeutics, Inc. 11 Aug 2025 1 -$113,713 4 Chief Development Officer 13 Aug 2025, 18:03
ALDX Aldeyra Therapeutics, Inc. 04 Mar 2025 1 $0 4 Chief Development Officer 06 Mar 2025, 16:13
ALDX Aldeyra Therapeutics, Inc. 12 Aug 2024 1 -$75,975 4 Chief Development Officer 14 Aug 2024, 16:24
ALDX Aldeyra Therapeutics, Inc. 12 Mar 2024 1 -$36,503 4/A Chief Development Officer 17 Apr 2024, 16:12
ALDX Aldeyra Therapeutics, Inc. 09 Mar 2024 3 -$98,605 4 Chief Development Officer 12 Mar 2024, 20:04
ALDX Aldeyra Therapeutics, Inc. 28 Feb 2023 1 $0 4 Chief Development Officer 02 Mar 2023, 15:27
ALDX Aldeyra Therapeutics, Inc. 15 Jul 2022 2 $0 4 Chief Development Officer 19 Jul 2022, 16:34
ALDX Aldeyra Therapeutics, Inc. 30 Mar 2022 2 $0 4 Chief Development Officer 01 Apr 2022, 19:37